Despite heightened volatility, it's shaping up to be another phenomenal year for Wall Street. This week, we've watched the iconic S&P 500 (SNPINDEX: ^GSPC) and growth-driven Nasdaq Composite (NASDAQINDEX: ^IXIC) trek to record highs, with the ageless Dow Jones Industrial Average (DJINDICES: ^DJI) eclipsing 50,000 earlier this year. While it would appear that nothing can stop this artificial intell...
Despite heightened volatility, it's shaping up to be another phenomenal year for Wall Street. This week, we've watched the iconic S&P 500 (SNPINDEX: ^GSPC) and growth-driven Nasdaq Composite (NASDAQINDEX: ^IXIC) trek to record highs, with the ageless Dow Jones Industrial Average (DJINDICES: ^DJI) eclipsing 50,000 earlier this year. While it would appear that nothing can stop this artificial intelligence (AI) -driven rally, Citadel's Founder and CEO, Ken Griffin, who oversees one of the most profitable hedge funds on the planet (Citadel Advisors), just offered a sobering take for investors . Image source: Getty Images. Continue reading
Canadian Natural Resources press release ( CNQ ): Q1 Non-GAAP EPS of C$1.17. Generated adjusted funds flow of approximately C$4.4 billion. Quarterly production averaged approximately 1,643,000 BOE/d in Q1/26, which included total quarterly liquids production of approximately 1,198,000 bbl/d, 66% of which was SCO, light crude oil and NGLs. We achieved record quarterly North American E&P production ...
Canadian Natural Resources press release ( CNQ ): Q1 Non-GAAP EPS of C$1.17. Generated adjusted funds flow of approximately C$4.4 billion. Quarterly production averaged approximately 1,643,000 BOE/d in Q1/26, which included total quarterly liquids production of approximately 1,198,000 bbl/d, 66% of which was SCO, light crude oil and NGLs. We achieved record quarterly North American E&P production for our conventional crude oil and natural gas business of approximately 773,000 BOE/d, consisting of record quarterly liquids production of approximately 329,000 bbl/d and record quarterly natural gas production of 2,668 MMcf/d. Total Company production in Q1/26 delivered year-over-year growth of 4% or approximately 61,000 BOE/d from Q1/25 levels. "We remain focused on executing our prudent and capital efficient 2026 capital program as outlined in our updated 2026 guidance previously released in March 2026." More on Canadian Natural Resources Limited Canadian Natural Resources: Earnings Set To Reveal Massive Rewards Canadian Natural: The Gold Standard Of Canadian Energy Canadian Natural Resources: Iran Rally Looks Like A Trap (Rating Downgrade) Canadian Natural Resources Non-GAAP EPS of C$0.82 beats by C$0.12; updates FY26 outlook Canadian Natural Resources Q4 2025 Earnings Preview
Artificial intelligence (AI) stocks led gains in the major benchmarks over the past few years, with chip designers, cloud computing stocks, and other key players roaring higher. They advanced in the triple and even quadruple digits as investors rushed to get in on what may be seen as the next big thing in technology. But in recent times, these players were put to the test. Late last year, investor...
Artificial intelligence (AI) stocks led gains in the major benchmarks over the past few years, with chip designers, cloud computing stocks, and other key players roaring higher. They advanced in the triple and even quadruple digits as investors rushed to get in on what may be seen as the next big thing in technology. But in recent times, these players were put to the test. Late last year, investors began to worry about the formation of an AI bubble as valuations of these stocks, and the S&P 500 in general, reached record levels. At the same time, tech giants spoke of their plans to continue pouring billions of dollars into AI infrastructure. This, too, sparked concern in the investment community, with the risk being that any dip in demand could leave these companies with extra capacity they might be unable to monetize. Meanwhile, the general investing environment was tough for growth stocks -- investors don't like uncertainty, and the war in Iran brought a big dose of uncertainty to the market. Continue reading
Schroptschop In March 2026, the seasonally adjusted retail trade volume decreased by 0.1% M/M in the euro area and increased by 0.3% in the EU, according to first estimates from Eurostat. In March 2026, compared with March 2025, the calendar adjusted retail sales index increased by 1.2% in the euro area and by 1.9% in the EU. More on Euro Area EUR/USD, GBP/USD Overview - FX Picks Up Again, U.S. Do...
Schroptschop In March 2026, the seasonally adjusted retail trade volume decreased by 0.1% M/M in the euro area and increased by 0.3% in the EU, according to first estimates from Eurostat. In March 2026, compared with March 2025, the calendar adjusted retail sales index increased by 1.2% in the euro area and by 1.9% in the EU. More on Euro Area EUR/USD, GBP/USD Overview - FX Picks Up Again, U.S. Dollar Tumbles After The ECB And BOE EUR/USD Drifted Down To 1.1665/1635 Key Support For Potential Bullish Reversal Dollar Reasserts Itself As Global Tensions Shift Currency Markets Europe equities mostly higher amid hopes of U.S.-Iran peace deal Europe equities gain as risk appetite returns
GameStop (NYSE: GME) surprised investors when it made a $56 billion, or $125 per share, offer to acquire eBay (NASDAQ: EBAY) . The shocking part of the proposal is that GameStop has a fraction of the market cap of the online auction site. The question is, does the deal make sense for GameStop? Making a large acquisition would be very beneficial to GameStop CEO Ryan Cohen, who, in January, received...
GameStop (NYSE: GME) surprised investors when it made a $56 billion, or $125 per share, offer to acquire eBay (NASDAQ: EBAY) . The shocking part of the proposal is that GameStop has a fraction of the market cap of the online auction site. The question is, does the deal make sense for GameStop? Making a large acquisition would be very beneficial to GameStop CEO Ryan Cohen, who, in January, received a $35 billion pay package tied to GameStop hitting a $100 billion market cap and achieving $10 billion in cumulative earnings before interest, taxes, depreciation, and amortization ( EBITDA ). If these goals were attained, he would receive options for 171.5 million shares at an exercise price of $20.66 per share. However, the awards have nine tranches, so he can get a portion of the award starting at a lower market cap hurdle of $20 billion and $2 billion in cumulative EBITDA. Continue reading
Retail group with 4,800 stores worldwide expects drop in profits this year amid ‘muted market’ Business live – latest updates The sports fashion retailer JD has warned that profits will fall this year amid a “muted market” hit by weaker spending by young people and concerns about the Middle East conflict. The company, which runs 4,800 stores worldwide including the JD, Blacks and Millets chains in...
Retail group with 4,800 stores worldwide expects drop in profits this year amid ‘muted market’ Business live – latest updates The sports fashion retailer JD has warned that profits will fall this year amid a “muted market” hit by weaker spending by young people and concerns about the Middle East conflict. The company, which runs 4,800 stores worldwide including the JD, Blacks and Millets chains in the UK, said it expected profits of between £750m and £850m in the year ahead, after reporting £852m in the year to the end of January. Continue reading...
Earnings Call Insights: Sight Sciences (SGHT) Q1 2026 Management View "We delivered a strong start to 2026 with first quarter results that demonstrated a return to double-digit revenue growth, continued strength in gross margin and disciplined operating expense and cash management," said Paul Badawi (Co-Founder, President, CEO & Director), adding, "Based on our performance and outlook, we are rais...
Earnings Call Insights: Sight Sciences (SGHT) Q1 2026 Management View "We delivered a strong start to 2026 with first quarter results that demonstrated a return to double-digit revenue growth, continued strength in gross margin and disciplined operating expense and cash management," said Paul Badawi (Co-Founder, President, CEO & Director), adding, "Based on our performance and outlook, we are raising our full year 2026 revenue guidance while maintaining our adjusted operating expense guidance." "We are very pleased by the commercial traction we generated with our dry eye customers in the first quarter, where we delivered revenue of $1.4 million," said CEO Badawi, and added, "We are increasing our Interventional Dry Eye revenue guidance by $1 million at the midpoint." "In April, the court issued its final judgment, which upheld the jury's finding of willful infringement by Alcon and confirmed past damages and interest totaling approximately $55 million as well as ongoing royalties of 10% of Hydrus revenue through patent expiration," CEO Badawi said, cautioning, "This ruling is subject to appeal, and no cash has been received to date." "We are executing against our strategic goals from a position of strength with the operating discipline and cost structure we need to support growth, and we believe this positions us to achieve cash flow breakeven without the need to raise additional equity capital," said Jim Rodberg (CFO & Treasurer). Outlook "We are raising revenue guidance to $83 million to $89 million" for 2026, CFO Rodberg said, "versus the prior guidance of $82 million to $88 million," while adding, "We are reaffirming our full year 2026 adjusted operating expense guidance of $93 million to $96 million." "This includes revenue for our Interventional Glaucoma segment of $77 million to $81 million" and "our Interventional Dry Eye segment of $6 million to $8 million," Rodberg said. For Q2, Rodberg said, "We expect total revenue to grow low-double digits compared to t...
Earnings Call Insights: Vanda Pharmaceuticals (VNDA) Q1 2026 Management view "Vanda delivered strong commercial execution in the first quarter, highlighted by 26% year-over-year growth in Fanapt sales, the groundbreaking U.S. launch of NEREUS with its pioneering direct-to-consumer platform at nereus.us and the FDA approval of BYSANTI." (Founder, President, CEO & Chairman of The Board Mihael Polyme...
Earnings Call Insights: Vanda Pharmaceuticals (VNDA) Q1 2026 Management view "Vanda delivered strong commercial execution in the first quarter, highlighted by 26% year-over-year growth in Fanapt sales, the groundbreaking U.S. launch of NEREUS with its pioneering direct-to-consumer platform at nereus.us and the FDA approval of BYSANTI." (Founder, President, CEO & Chairman of The Board Mihael Polymeropoulos) "Full year 2026 revenue guidance was raised to $240 million to $290 million, including $10 million to $30 million from newly launched NEREUS." (CEO Polymeropoulos) "BYSANTI, milsaperidone received FDA approval for the treatment of bipolar I disorder and schizophrenia" and "is protected by data exclusivity through February 20, 2031, and multiple patents, the latest of which expires on May 31st, 2044." (CEO Polymeropoulos) "The FDA accepted the biologic license application for imsidolimab in Generalized Pustular Psoriasis with a Prescription Drug User Fee Act target action date of December 12, 2026." (CEO Polymeropoulos) "Total revenues for the first quarter of 2026 were $51.7 million" and the sequential decline was "primarily driven by the impact of insurance plan disruptions and deductible resets that are typical in the industry at the beginning of the year." (Senior VP, CFO & Treasurer Kevin Moran) Outlook "Vanda is raising its full year 2026 total revenue guidance to reflect the potential contribution of newly launched NEREUS while maintaining prior ranges for Fanapt and other products." (CFO Moran) "Total revenues from Fanapt, HETLIOZ, PONVORY and NEREUS of between $240 million and $290 million." (CFO Moran) "Fanapt net product sales of between $150 million and $170 million" with the range tied to sequential prescription growth assumptions for the remainder of 2026. (CFO Moran) "Other net product sales of between $80 million and $90 million" assuming "a further decline of the HETLIOZ business due to generic competition" and "modest growth of the PONVORY busines...
Robert Way Anthropic’s ( ANTHRO ) launch of “ready-to-run” AI finance agents could streamline core banking tasks, though the impact on jobs may take time to materialize, according to a Deutsche Bank Research Institute note. The company introduced 10 agent templates aimed at automating functions across research, client coverage, and operations. The tools integrate third-party data, sub-agents, and ...
Robert Way Anthropic’s ( ANTHRO ) launch of “ready-to-run” AI finance agents could streamline core banking tasks, though the impact on jobs may take time to materialize, according to a Deutsche Bank Research Institute note. The company introduced 10 agent templates aimed at automating functions across research, client coverage, and operations. The tools integrate third-party data, sub-agents, and workflows, allowing bankers to build pitchbooks, run comparable analyses, screen KYC files, and close month-end accounts with reduced manual effort, the note said. Despite online concerns over job losses, the report suggested junior bankers are unlikely to see immediate relief from long hours, as adoption across financial institutions remains gradual. Finance is well-positioned for AI given its data-heavy nature and reliance on repeatable processes. About 30% of U.S. banks and insurers are already using AI, with another 34% planning adoption within six months, according to U.S. Census Bureau data cited in the Deutsche Bank note. However, barriers to implementation remain significant. Integrating AI into legacy systems, ensuring secure and high-quality data, and addressing risks around bias, hallucination, and intellectual property all complicate deployment. Regulatory uncertainty and the need for explainable systems add further friction, while firms must also manage internal resistance and limited technical expertise. Client willingness to rely on AI for financial decisions remains uncertain. The note outlined three phases of adoption: individual productivity tools, process automation, and full system transformation. While early use cases are advancing, more complex applications such as autonomous trading remain nascent and risky. Over time, AI is expected to reshape rather than replace roles, with human judgment, creativity, and emotional intelligence remaining critical. The note said extracting value from AI will depend less on the technology itself and more on how effect...
quantic69 Stock futures advanced Thursday morning as optimism grew over a potential diplomatic breakthrough in the Middle East. Investors are closely monitoring Tehran’s expected response to a U.S.-backed peace proposal, which has already helped stabilize energy markets and lowered Brent crude toward the $100 mark. Here are some of Thursday's biggest stock movers: Biggest stock gainers Cross Count...
quantic69 Stock futures advanced Thursday morning as optimism grew over a potential diplomatic breakthrough in the Middle East. Investors are closely monitoring Tehran’s expected response to a U.S.-backed peace proposal, which has already helped stabilize energy markets and lowered Brent crude toward the $100 mark. Here are some of Thursday's biggest stock movers: Biggest stock gainers Cross Country Healthcare ( CCRN ) +27% - Shares soared after announcing it will be acquired by Knox Lane in a $437M all-cash deal. Shareholders will receive $13.25 per share, representing a ~31% premium to the prior close and about 45% above the stock’s 90-day average price. Following the transaction, Cross Country Healthcare will become a private company and will be delisted from Nasdaq, while continuing to operate under its existing brand. The deal is expected to close in Q3 2026, subject to shareholder and regulatory approvals. Fortinet ( FTNT ) +13% - Shares surged after reporting strong Q1 results that topped expectations, with adjusted EPS of $0.82 and revenue rising 20% Y/Y to $1.85B, both well ahead of consensus. The company also posted an adjusted operating margin of 35.8%, exceeding estimates. The company expects Q2 adjusted EPS of $0.72–$0.76 and revenue of $1.83B–$1.93B, both above Wall Street forecasts. The company also raised its FY2026 revenue outlook to $7.71B–$7.87B from its prior range of $7.5B–$7.7B. Biggest stock losers Fastly ( FSLY ) -20% - Shares plunged despite reporting better-than-expected Q1 results, as investors focused on softer guidance and ongoing concerns around growth sustainability. Revenue rose nearly 20% Y/Y, supported by 47% growth in Security revenue and 67% growth in Other revenue, while record remaining performance obligations climbed 63% to $369M. For Q2, Fastly expects revenue of $170M–$176M and non-GAAP EPS of $0.05–$0.08, broadly in line with expectations. The company also guided FY2026 revenue to $710M–$725M and EPS to $0.27–$0.33. Snap ( S...